Figure 1From: Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators The flow of subjects (including number of subjects) through the trial from enrollment and into each of the extension phases Back to article page